U.S. Food and Drug Administration (FDA) warned Rena's Organic over unapproved CBD drug claims for tinctures, creams, foods, and pet product.
What happened
FDA reviewed the company's website in February 2022 and its Facebook and Instagram pages, which direct consumers to the site to buy CBD products. FDA found claims that the CBD tinctures, creams, cider, and food treat cancer, opioid addiction, ADHD, insomnia, pain, and other conditions, plus a CBD pet product. FDA said these are unapproved new human and animal drugs, misbranded drugs (drugs with unlawful labeling), and foods with added CBD.
What FDA found
CBD tinctures, creams, cider, and food are promoted as drugs for diseases but are not FDA-approved.
FD&C Act §§505(a), 301(d); 21 U.S.C. 355(a), 331(d)These CBD products lack adequate directions for use and are therefore misbranded.
FD&C Act §502(f)(1); 21 U.S.C. 352(f)(1)The Pain Relief Creams are unapproved external analgesic drugs, and CBD is not a permitted active ingredient.
FD&C Act §§505(a), 301(d), 505G; 21 U.S.C. 355(a), 331(d), 355hThe Pain Relief Creams are misbranded because labeling features CBD as an inactive ingredient while implying it has active value.
FD&C Act §502(a); 21 CFR 201.10(c)(4)CBD added to conventional foods such as CBD Super Cider and CBD Super Food is prohibited and makes the food adulterated.
FD&C Act §§301(ll), 409(a), 402(a)(2)(C)(i); 21 U.S.C. 331(ll), 348(a), 342(a)(2)(C)(i)The pet CBD product is an unapproved new animal drug and is unsafe and adulterated.
FD&C Act §§512(a), 501(a)(5); 21 U.S.C. 360b(a), 351(a)(5)
What FDA wants
FDA tells the company to correct the violations and warns that failure to do so may lead to legal action. The provided letter excerpt does not state a response deadline.
Who should pay attention
- CBD brands making disease treatment claims
- retailers and marketplaces selling CBD tinctures, creams, or foods
- pet supplement sellers and contract manufacturers of CBD products
This is a summary. Read the original letter on fda.gov.